The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
The Molecular Basis of Antibiotic Action
Gale, E. F. (1981) · Medical Entomology and Zoology · Cited by 1,217
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
Oxidative stress responses in Escherichia coli and Salmonella typhimurium
Farr, S. B., & Kogoma, T. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.4.561-585.1991 · Cited by 1,091
MOLECULAR BIOLOGY OF THE LysR FAMILY OF TRANSCRIPTIONAL REGULATORS
Schell, M. A. (1993) · Annual Review of Microbiology · doi:10.1146/annurev.mi.47.100193.003121 · Cited by 1,055
Christman, M. F., Morgan, R. W., Jacobson, F. S., & Ames, B. N. (1985) · Cell · doi:10.1016/s0092-8674(85)80056-8 · Cited by 1,029
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationDaley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
The Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 939
Transcriptional Regulator of Oxidative Stress-Inducible Genes: Direct Activation by Oxidation
Storz, G., Tartaglia, L. A., & Ames, B. N. (1990) · Science · doi:10.1126/science.2183352 · Cited by 874
Edlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Fourmy, D., Recht, M. I., Blanchard, S. C., & Puglisi, J. D. (1996) · Science · doi:10.1126/science.274.5291.1367 · Cited by 829
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
Pablos-Méndez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S. B., Kim, S. J., Chaulet, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382301 · Cited by 815
Noller, H. F. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.001003 · Cited by 792
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Treatment of Multidrug-Resistant Tuberculosis
Wood, A. J. J., & Iseman, M. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291108 · Cited by 706
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Pelletier, H., & Kraut, J. (1992) · Science · doi:10.1126/science.1334573 · Cited by 676
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Self-citationThe Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589
Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., & Ellner, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 535
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
Small, P. M., Shafer, R. W., Hopewell, P. C., Singh, S. P., Murphy, M. J., Desmond, E., Sierra, M. F., & Schoolnik, G. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281601 · Cited by 512
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Self-citationBelanger, A. E., Besra, G. S., Ford, M. E., Mikusová, K., Belisle, J. T., Brennan, P. J., & Inamine, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11919 · Cited by 466
Jacobs, W. R., Barletta, R. G., Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G. J., Hatfull, G. F., & Bloom, B. R. (1993) · Science · doi:10.1126/science.8484123 · Cited by 439
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Quinolone antimicrobial agents
(1989) · International Journal of Biochemistry · doi:10.1016/0020-711x(89)90066-9 · Cited by 407
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Self-citationToledano, M. B., Kullik, I., Trinh, F., Baird, P. T., Schneider, T. D., & Storz, G. (1994) · Cell · doi:10.1016/s0092-8674(94)90702-1 · Cited by 388
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Multidrug-resistant Tuberculosis
Dooley, S. W., Jarvis, W. R., Marione, W. J., & Snider, D. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-257 · Cited by 376
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Fischl, M. A., Uttamchandani, R. B., Daikos, G. L., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., & Lai, S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-177 · Cited by 371
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Transmission of Multidrug-Resistant Mycobacterium tuberculosis during a Long Airplane Flight
Kenyon, T. A., Valway, S. E., Ihle, W. W., Onorato, I. M., & Castro, K. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341501 · Cited by 357
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Self-citationCharacterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., & Zhang, Y. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.540 · Cited by 333
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
Kapur, V, Li, L. L., Iordanescu, S., Hamrick, M. R., Wanger, A., Kreiswirth, B. N., & Musser, J. M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1095-1098.1994 · Cited by 317
Self-citationMusser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Self-citationOn the mechanism of rifampicin inhibition of RNA synthesis.
McClure, W. R., & Cech, C. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34269-2 · Cited by 310
Nationwide Survey of Drug-Resistant Tuberculosis in the United States
Bloch, A. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510330043032 · Cited by 304
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Wolucka, B. A., McNeil, M. R., de Hoffmann, E., Chojnacki, T., & Brennan, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31657-5 · Cited by 272
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Go, M. F., Kapur, V, Graham, D. Y., & Musser, J. M. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3934-3938.1996 · Cited by 251
Self-citationFischl, M. A., Daikos, G. L., Uttamchandani, R. B., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., Oldham, S. A., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-184 · Cited by 248
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., & Gillis, T. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1853 · Cited by 236
Rossau, R., Traore, H., De Beenhouwer, H., Mijs, W., Jannes, G., De Rijk, P., & Portaels, F. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2093 · Cited by 231
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
De Beenhouwer, H., Lhiang, Z., Jannes, G., Mijs, W., Machtelinckx, L., Rossau, R., Traore, H., & Portaels, F. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90009-8 · Cited by 220
Mahmoudi, A. (1993) · JAMA · doi:10.1001/jama.270.1.65 · Cited by 219
Pablos-Méndez, A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150025026 · Cited by 218
Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli
Middlebrook, G., & Cohn, M. L. (1953) · Science · doi:10.1126/science.118.3063.297 · Cited by 217
Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis
Chaulk, C. P. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530120037038 · Cited by 217
Zhou, Y. N., & Jin, D. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2908 · Cited by 215
Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
Heym, B., Zhang, Y., Poulet, S., Young, D., & Cole, S. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.13.4255-4259.1993 · Cited by 214
Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Present aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
Multidrug-Resistant Tuberculosis in Patients without HIV Infection
Telzak, E. E., Sepkowitz, K., Alpert, P., Mannheimer, S., Medard, F., El-Sadr, W., Blum, S., Gagliardi, A., Salomon, N., & Turett, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510053331404 · Cited by 208
Kapur, V., Li, L., Hamrick, M. R., et al. (1995) · PubMed · Cited by 203
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.
Sherman, D. R., Sabo, P. J., Hickey, M. J., Arain, T. M., Mahairas, G. G., Yuan, Y., Barry, C. E., & Stover, C. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6625 · Cited by 202
Tartaglia, L. A., Storz, G., & Ames, B. N. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90104-6 · Cited by 202
Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Chambers, H. F., Moreau, D., Yajko, D., Miick, C., Wagner, C., Hackbarth, C., Kocagöz, S., Rosenberg, E., Hadley, W. K., & Nikaido, H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2620 · Cited by 197
Hopewell, P. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.540 · Cited by 196
Li, Z., Kelley, C., Collins, F., Rouse, D., & Morris, S. (1998) · Journal of Infectious Diseases · doi:10.1086/515254 · Cited by 195
Huang, W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1183 · Cited by 191
Wenger, P. N., Beck-Sague, C. M., Jarvis, W. R., Otten, J., Breeden, A., & Orfas, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90228-7 · Cited by 181
Sepkowitz, K. A., Raffalli, J., Riley, L., Kiehn, T. E., & Armstrong, D. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.180 · Cited by 181
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Suzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Deretic, V., Philipp, W., Dhandayuthapani, S., Mudd, M. H., Curcic, R., Garbe, T., Heym, B., Via, L. E., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17050889.x · Cited by 177
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
Shafer, R. W., & Edlin, B. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.683 · Cited by 174
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Is Mycobacterium tuberculosis 15,000 Years Old?
Kapur, V., Whittam, T. S., & Musser, J. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1348 · Cited by 165
Self-citationRitacco, V., Di Lonardo, M., Reniero, A., Ambroggi, M., Barrera, L., Dambrosi, A., Lopez, B., Isola, N., & de Kantor, I. N. (1997) · The Journal of Infectious Diseases · doi:10.1086/514084 · Cited by 163
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.
Park, M. M., Davis, A. L., Schluger, N. W., Cohen, H., & Rom, W. N. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542137 · Cited by 161
Johnsson, K., Froland, W. A., & Schultz, P. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2834 · Cited by 160
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Trends in Drug-Resistant Tuberculosis in the United States, 1993-1996
Moore, M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550100059039 · Cited by 159
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Wilson, S. M., Al-Suwaidi, Z., McNerney, R., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-465 · Cited by 157
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis
Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S.-I. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08515.x · Cited by 154
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Self-citationDrug-resistant tuberculosis: laboratory issues
Vareldzis, B., Grosset, J. H. E., Kantor, I. N., Crofton, J., Laszlo, A., Felten, M., Raviglione, M. C., & Kochi, A. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90096-5 · Cited by 150
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex
Wilson, T. M., & Collins, D. M. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.449980.x · Cited by 148
Activity of Amoxicillin/Clavulanate in Patients with Tuberculosis
Chambers, H. F. “., Kocagöz, T., Şipit, T., Turner, J., & Hopewell, P. C. (1998) · Clinical Infectious Diseases · doi:10.1086/513945 · Cited by 146
Improved Outcomes for Patients with Multidrug-Resistant Tuberculosis
Turett, G. S., Telzak, E. E., Torian, L. V., Blum, S., Alland, D., Weisfuse, I. B., & Fazal, B. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1238 · Cited by 140
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
Hirano, K., Takahashi, M., Kazumi, Y., Fukasawa, Y., & Abe, C. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80004-x · Cited by 138
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 135
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Self-citationHeym, B., Stavropoulos, E., Honoré, N., Domenech, P., Saint‐Joanis, B., Wilson, T. M., Collins, D. M., Colston, M. J., & Cole, S. T. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1395-1401.1997 · Cited by 131
Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis
Sreevatsan, S., Escalante, P., Pan, X., Gillies, D. A., Siddiqui, S., Khalaf, C. N., Kreiswirth, B. N., Bifani, P. J., Adams, L. G., Ficht, T. A., et al. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.8.2007-2010.1996 · Cited by 130
Self-citationBodmer, T., Zürcher, G., Imboden, P., et al. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.345 · Cited by 123
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
Ordway, D. J., Sonnenberg, M. G., Donahue, S. A., Belisle, J. T., & Orme, I. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.741-743.1995 · Cited by 120
Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid
Zhang, Y., Dhandayuthapani, S., & Deretic, V. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13212 · Cited by 120
Dhandayuthapani, S., Zhang, Y., Mudd, M. H., & Deretic, V. P. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.12.3641-3649.1996 · Cited by 119
Carrière, C., Riska, P. F., Zimhony, O., Kriakov, J., Bardarov, S., Burns, J., Chan, J., & Jacobs, W. R. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3232-3239.1997 · Cited by 118
Haas, W., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V., & Bremer, H. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1601 · Cited by 115
Cockerill, F. R., Uhl, J. R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., & Kline, B. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.240 · Cited by 114
Mdluli, K. E., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S. L., Stover, C. K., & Barry, C. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1085 · Cited by 112
Kelley, C. L., Rouse, D. A., & Morris, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2057 · Cited by 110
Nelson, K., & Selander, R. K. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.21.6886-6895.1992 · Cited by 109
Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis
Takayama, K., Armstrong, E. L., Kunugi, K. A., & Kilburn, J. O. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.2.240 · Cited by 108
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Cooksey, R. C., Morlock, G. P., McQueen, A., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1186 · Cited by 107
Cooksey, R. C., Morlock, G. P., Glickman, S. E., & Crawford, J. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.5.1281-1283.1997 · Cited by 107
Global Epidemiology of Tuberculosis
Raviglione, M. C., Snider, D. E., & Kochi, A. (1996) · Survey of Anesthesiology · doi:10.1097/00132586-199604000-00069 · Cited by 107
Interaction of ribosomal proteins S5, S6, S11, S12, S18 and S21 with 16 S rRNA
Stern, S., Powers, T., Changchien, L., & Noller, H. F. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90467-6 · Cited by 106
RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance
Ovchinnikov, Y. A., MONASTYRSKAYA, G. S., Guriev, S. O., Nf, K., Sverdlov, E. D., Gragerov, A., Bass, I. A., Kiver, I. F., Moiseeva, E. P., Igumnov, V. N., et al. (1983) · Molecular and General Genetics MGG · doi:10.1007/bf00330662 · Cited by 105
Levin, M. E., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01572.x · Cited by 103
Predictors and Outcome of Multidrug-Resistant Tuberculosis
Salomon, N., Perlman, D. C., Friedmann, P., Buchstein, S., Kreiswirth, B. N., & Mildvan, D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1245 · Cited by 99
Cohn, M. L., Kovitz, C., ODA, U., & Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.70.4.641 · Cited by 98
Taniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA
Bradford, W. Z., Martin, J. N., Reingold, A. L., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03027-9 · Cited by 91
Blázquez, J., Monteros, L. E. E. D. L., Samper, S., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1390-1393.1997 · Cited by 90
Quémard, A., Dessen, A., Sugantino, M., Jacobs, W. R., Sacchettini, J. C., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja950998b · Cited by 90
A Nosocomial Outbreak of Multidrug-Resistant Tuberculosis
Kenyon, T. A., Ridzon, R., Luskin-Hawk, R., Schultz, C., Paul, W. S., Valway, S. E., Onorato, I. M., & Castro, K. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-1-199707010-00006 · Cited by 84
Lisitsyn, N. A., Sverdlov, E. D., Moiseeva, E. P., Danilevskaya, O. N., & Nikiforov, V. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00334112 · Cited by 84
Nosocomial Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Spain
Rullán, J. V., Herrera, D., Cano, R., Moreno, V., Godoy, P., Peiró, E. F., Castell, J., Ibañez, C., Ortega, A., Agudo, L. S., et al. (1996) · Emerging infectious diseases · doi:10.3201/eid0202.960208 · Cited by 79
Organization of rRNA genes in Mycobacterium bovis BCG
Suzuki, Y., Yoshinaga, K., Ono, Y., et al. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.2.839-843.1987 · Cited by 78
Marttila, H., Soini, H., Huovinen, P., & Viljanen, M. K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2187 · Cited by 76
Nachamkin, I., Kang, C., & Weinstein, M. P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.894 · Cited by 76
Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium tuberculosis bcg
Winder, F. G., Collins, P. B., & Whelan, D. (1971) · Journal of General Microbiology · doi:10.1099/00221287-66-3-379 · Cited by 75
Stoeckle, M. Y., Guan, L. L., Riegler, N., Weitzman, I., Kreiswirth, B. N., Kornblum, J. S., Laraque, F., & Riley, L. W. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1063 · Cited by 70
Lety, M. A., Nair, S., Berche, P., & Escuyer, V. E. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2629 · Cited by 67
Williams, D. L., Spring, L., Gillis, T. P., Salfinger, M., & Persing, D. H. (1998) · Clinical Infectious Diseases · doi:10.1086/516313 · Cited by 66
Ridzon, R., Kent, J. H., Valway, S. E., Weismuller, P. C., Maxwell, R. M., Elcock, M., Meador, J., Royce, S., Shefer, A. M., Smith, P. J., et al. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70034-9 · Cited by 63
Dhandayuthapani, S., Mudd, M. H., & Deretic, V. P. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2401-2409.1997 · Cited by 62
A Ribosomal Gene Mutation in Streptomycin-ResistantMycobacterium tuberculosis Isolates
Douglass, J., & Steyn, L. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1505 · Cited by 62
Pretorius, G. S., van Helden, P. D., Sirgel, F. A., Eisenach, K. D., & Victor, T. C. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2276 · Cited by 60
Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994
Munsiff, S. S., Joseph, S., Ebrahimzadeh, A., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/516146 · Cited by 60
Recombinant Expression and Characterization of the Major β-Lactamase of Mycobacterium tuberculosis
Voladri, R. K. R., Lakey, D. L., Hennigan, S. H., Menzies, B. E., Edwards, K. M., & Kernodle, D. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1375 · Cited by 59
Zabinski, R. F., & Blanchard, J. S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9639731 · Cited by 59
Loss of oxyR in Mycobacterium tuberculosis
Deretic, V. P., Song, J., & Pagán-Ramos, E. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01112-8 · Cited by 58
Yew, W. W., Wong, C. F., Wong, P. C., Lee, J., & Chau, C. H. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.2.288 · Cited by 57
Feizabadi, M. M., Robertson, I., Cousins, D., & Hampson, D. J. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.5.1136-1142.1996 · Cited by 56
Deretic, V. P., Pagán-Ramos, E., Zhang, Y., Dhandayuthapani, S., & Via, L. E. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1557 · Cited by 54
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid
Rosner, J. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2251 · Cited by 51
Jerlström, P. G., Bezjak, D. A., Jennings, M. P., et al. (1989) · Gene · doi:10.1016/0378-1119(89)90312-0 · Cited by 45
Treatment of Multidrug-Resistant Tuberculosis
(1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291926 · Cited by 43
Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra
Hackbarth, C. J., Ünsal, İ., & Chambers, H. F. “. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1182 · Cited by 41
Basso, L. A., Zheng, R., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja962035y · Cited by 39
Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991
Sepkowitz, K. A., Telzak, E. E., Recalde, S., Armstrong, D., & the New York City Area Tuberculosis Working Group (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.755 · Cited by 39
Nelson, K., Wang, F., Boyd, E. F., & Selander, R. K. (1997) · Genetics · doi:10.1093/genetics/147.4.1509 · Cited by 38
Rapid detection of multidrug-resistant tuberculosis
Goyal, M., Shaw, R., Banerjee, D., Coker, R., Robertson, B. D., & Young, D. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051120 · Cited by 36
katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent
Victor, T. C., Pretorius, G. S., Felix, J. V., Jordaan, A. M., van Helden, P. D., & Eisenach, K. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1572 · Cited by 30
Cangelosi, G. A., Brabant, W. H., Britschgi, T. B., & Wallis, C. K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1790 · Cited by 28
Wheeler, P. R., & ANDERSON, P. M. (1996) · Biochemical Journal · doi:10.1042/bj3180451 · Cited by 27
Ferrazoli, L., Palaci, M., Telles, M. A. D. S., Ueki, S. Y. M., Kritski, A. L., Marques, L. R. M., Ferreira, O. C., & Riley, L. W. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.237 · Cited by 20
The ethionamide sensitivity of british pre-treatment strains of mycobacterium tuberculosis
Lefford, M. J. (1966) · Tubercle · doi:10.1016/s0041-3879(66)80036-3 · Cited by 16
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay
Miyamoto, J., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.5.1323-1326.1996 · Cited by 15
Cited by
Diversity of structures and properties among catalases
Chelikani, P., Fita, I., & Loewen, P. C. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3206-5 · Cited by 1,700
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Mycobacterium abscessus: a new antibiotic nightmare
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr578 · Cited by 799
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Metadata
- Authors
- Ramaswamy, S., & Musser, J. M.
- Venue
- Tubercle and Lung Disease
- Publisher
- Elsevier BV
- Published
- 1998
- Volume
- 79
- Issue
- 1
- Pages
- 3-29
- ISSN
- 0962-8479 (ISSN-L)
- OpenAlex
- W2119603196
- Cited by
- 1,089
- References
- 176
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.